| abstract |
In its many embodiments, the present invention provides a new class of pyrazolo [1,5-a] pyrimidine compounds as inhibitors of cyclin-dependent kinases, methods of preparing said compounds, pharmaceutical compositions containing one or more of said compounds, methods for the preparation of pharmaceutical formulations comprising one or more such compounds; and methods for the treatment, prevention, inhibition or improvement of one or more diseases associated with CDK using said pharmaceutical compounds or compositions. |